Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

Several properties of pancreatic beta-cells in type 2 diabetes (T2D) were studied by using islets isolated from T2D subjects. Moreover, because metformin has protective effects on nondiabetic beta-cells exposed to high glucose or free fatty acid levels, we investigated its direct action on T2D islet cells. Diabetic islets were characterized by reduced insulin content, decreased amount of mature insulin granules, impaired glucose-induced insulin secretion, reduced insulin mRNA expression, and increased apoptosis with enhanced caspase-3 and -8 activity. These alterations were associated with increased oxidative stress, as shown by higher nitrotyrosine concentrations, increased expression of protein kinase C-beta2 and nicotinamide adenine dinucleotide phosphate reduced-oxidase, and changes in mRNA expression of manganese- superoxide dismutase, Cu/Zn-superoxide dismutase, catalase, and glutathione peroxidase. Twenty-four-hour incubation of T2D islets with metformin was associated with increased insulin content, increased number and density of mature insulin granules, improved glucose-induced insulin release, and increased insulin mRNA expression. Moreover, apoptosis was reduced, with concomitant decrease of caspase-3 and -8 activity. These changes were accompanied by reduction or normalization of several markers of oxidative stress. Thus, T2D islets have several functional and survival defects, which can be ameliorated by metformin; the beneficial effects of the drug are mediated, at least in part, by a reduction of oxidative stress.

[1]  U. Boggi,et al.  Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. , 2004, American journal of physiology. Endocrinology and metabolism.

[2]  B. Wolf,et al.  Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. , 2004, Diabetes.

[3]  M. Lorenzo,et al.  Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes , 2003, Diabetologia.

[4]  Antonio Ceriello,et al.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.

[5]  R. Robertson,et al.  Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. , 2003, Diabetes.

[6]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[7]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[8]  I. Goldfine,et al.  Are Oxidative StressActivated Signaling Pathways Mediators of Insulin Resistance and -Cell , 2003 .

[9]  Joseph L Evans,et al.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.

[10]  C. Boitard.  Insulin secretion in type 2 diabetes: clinical aspects. , 2002, Diabetes & metabolism.

[11]  P. Vignais.  The superoxide-generating NADPH oxidase: structural aspects and activation mechanism , 2002, Cellular and Molecular Life Sciences CMLS.

[12]  Samy I McFarlane,et al.  Metformin: An Update , 2002, Annals of Internal Medicine.

[13]  U. Boggi,et al.  Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism. , 2002, Diabetes.

[14]  U. Boggi,et al.  Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. , 2002, Diabetes.

[15]  R. Gomis,et al.  Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. , 2002, Diabetes.

[16]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[17]  U. Boggi,et al.  Lipotoxicity in human pancreatic islets and the protective effect of metformin. , 2002, Diabetes.

[18]  Piero Marchetti,et al.  Phasic insulin release and metabolic regulation in type 2 diabetes. , 2002, Diabetes.

[19]  S. Yagihashi,et al.  Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients , 2002, Diabetologia.

[20]  C. Wollheim,et al.  Mitochondrial function in normal and diabetic β-cells , 2001, Nature.

[21]  U. Boggi,et al.  Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  J. Lakey,et al.  Modulation of JNK and p38 Stress Activated Protein Kinases In Isolated Islets of Langerhans: Insulin as an Autocrine Survival Signal , 2001, Annals of surgery.

[23]  K. Polonsky,et al.  Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. , 2000, The Journal of clinical investigation.

[24]  P. Djordjević,et al.  Effect of four‐week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes , 2000, Diabetes, obesity & metabolism.

[25]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[26]  J. McCord,et al.  The evolution of free radicals and oxidative stress. , 2000, The American journal of medicine.

[27]  P. Marchetti,et al.  Function of pancreatic islets isolated from a type 1 diabetic patient. , 2000, Diabetes care.

[28]  B. Tan,et al.  Antihyperglycaemic And Anti‐Oxidant Properties Of Andrographis Paniculata In Normal And Diabetic Rats , 2000, Clinical and experimental pharmacology & physiology.

[29]  R. Vigneri,et al.  Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. , 2000, Diabetes.

[30]  S. Kahn.  The importance of the β-cell in the pathogenesis of type 2 diabetes mellitus , 2000 .

[31]  M. Rigoulet,et al.  Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.

[32]  R. Robertson,et al.  Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Favier,et al.  An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. , 1999, Diabetes.

[34]  P. Marchetti,et al.  The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose. , 1999, European journal of pharmacology.

[35]  E. Ferrannini.  Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. , 1998, Endocrine reviews.

[36]  V. Kidd,et al.  Proteolytic activities that mediate apoptosis. , 1998, Annual review of physiology.

[37]  S. Lenzen,et al.  Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.

[38]  M. Fantone,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.

[39]  P. Lacy,et al.  Metformin Potentiates Glucose-Stimulated Insulin Secretion , 1996, Diabetes Care.

[40]  J. Levy,et al.  U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease , 1995, Diabetes.

[41]  N. Heintz,et al.  Differential regulation of antioxidant enzymes in response to oxidants. , 1991, The Journal of biological chemistry.

[42]  P. Marchetti,et al.  Metformin potentiates B-cell response to high glucose: an in vitro study on isolated perfused pancreas from normal rats. , 1989, Diabete & metabolisme.

[43]  E. Weibel.  Stereological principles for morphometry in electron microscopic cytology. , 1969, International review of cytology.